SCHEMBL6982049

SCHEMBL6982049

O=Cc1c(OC[C@@H]2CO2)ccc(F)c1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
GLA P06280 1/20 0.43
PKM P14618 2/20 0.41
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.41
HTR2A P28223 2/20 0.40
SLC6A4 P31645 2/20 0.40
TDP1 Q9NUW8 1/20 0.39
TP53 P04637 3/20 0.38
TSHR P16473 3/20 0.38
HIF1A Q16665 2/20 0.38
CYP3A4 P08684 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MAPT P10636 2/20 0.35
HPGD P15428 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
CYP1A2 P05177 1/20 0.35
PPARG P37231 1/20 0.35
VDR P11473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6982056 1.00 ALDH1A1 (0.43) ALDH1A1GLAPKMLMNAGAA
SCHEMBL6982051 1.00 ALDH1A1 (0.43) ALDH1A1GLAPKMLMNAGAA
SCHEMBL6975232 0.83 ALDH1A1 (0.41) ALDH1A1GLAPKMLMNAGAA
SCHEMBL6975228 0.83 ALDH1A1 (0.41) ALDH1A1GLAPKMLMNAGAA
SCHEMBL6983423 0.82 ALDH1A1 (0.50) ALDH1A1GLAPKMLMNAGAA
SCHEMBL6983424 0.82 ALDH1A1 (0.50) ALDH1A1GLAPKMLMNAGAA
SCHEMBL28892599 0.82 HTR2C (0.38) HTR2AHTR2CHTR2B
SCHEMBL3363155 0.74 LMNA (0.42) ALDH1A1LMNAGAATDP1TSHR
SCHEMBL22163944 0.74 MAPT (0.58) ALDH1A1GLAPKMLMNAGAA
SCHEMBL654030 0.74 MAPT (0.58) ALDH1A1GLAPKMLMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839145-B1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS ABBOTT GMBH & CO KG (DE) 2003-11-05 EP disclosed
US-5935973-A AFFINITY FOR 5-HT1A, ALPHA1, ALPHA2 AND/OR D2 RECEPTORS; ANTIDEPRESSANTS, ANXIOLYTIC AGENTS, PSYCHOSES, DYSKINESIAS, PARKINSON'S DISEASE, HYPOTENSIVE AGENTS, TOURETTE'S SYNDROME, OBSESSIVE-COMPULSIVE BEHAVIOUR, PANIC ATTACKS, SOCIAL PHOBIAS KNOLL AKTIENGESELLSCHAFT (DE) 1999-08-10 US disclosed
EP-0839145-A1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS Knoll AG (DE) 1998-05-06 EP disclosed
WO-1997003071-A1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS KNOLL AKTIENGESELLSCHAFT (DE) 1997-01-30 WO disclosed